Aquestive Therapeutics (AQST) Shares Outstanding (Entity) (2018 - 2026)
Powered by 
Analysis
Aquestive Therapeutics (AQST) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Aquestive Therapeutics | 635.60 Mn | 537.11 Mn | 9.80 Mn | 125.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.51 Mn |
| Mar 31, 2026 | 124.28 Mn |
| Dec 31, 2025 | 122.04 Mn |
| Sep 30, 2025 | 121.66 Mn |
| Jun 30, 2025 | 99.35 Mn |
| Mar 31, 2025 | 99.32 Mn |
| Dec 31, 2024 | 91.41 Mn |
| Sep 30, 2024 | 91.18 Mn |
| Jun 30, 2024 | 91.06 Mn |
| Mar 31, 2024 | 73.61 Mn |
| Dec 31, 2023 | 68.53 Mn |
| Sep 30, 2023 | 66.74 Mn |
| Jun 30, 2023 | 61.62 Mn |
| Mar 31, 2023 | 55.92 Mn |
| Dec 31, 2022 | 54.83 Mn |
| Sep 30, 2022 | 53.85 Mn |
| Jun 30, 2022 | 53.34 Mn |
| Mar 31, 2022 | 41.62 Mn |
| Dec 31, 2021 | 41.23 Mn |
| Sep 30, 2021 | 40.08 Mn |